Risks of Incident Cardiovascular Disease Associated With Concomitant Elevations in Lipoprotein(a) and Low‐Density Lipoprotein Cholesterol—The Framingham Heart Study

Background Elevated lipoprotein(a) is a well‐established risk factor for atherosclerotic vascular disease but is not measured in routine clinical care. Screening of high lipoprotein(a) in individuals with moderate elevations of low‐density lipoprotein cholesterol (LDL‐C) may identify individuals at...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Mehdi Afshar, Jian Rong, Yang Zhan, Hao Yu Chen, James C. Engert, Allan D. Sniderman, Martin G. Larson, Ramachandran S. Vasan, George Thanassoulis
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Wiley 2020-09-01
coleção:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Assuntos:	cardiovascular disease dyslipidemia Framingham lipoprotein(a)
Acesso em linha:	https://www.ahajournals.org/doi/10.1161/JAHA.119.014711
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!